
LabGenius develops next-generation antibody and protein therapeutics to improve selectivity and tumor cell killing. The company applies a machine learning–driven evolution engine (EVA) that combines…

LabGenius develops next-generation antibody and protein therapeutics to improve selectivity and tumor cell killing. The company applies a machine learning–driven evolution engine (EVA) that combines…
Headquarters & founding: London; founded 2012
Core tech: EVA™ — ML-driven discovery engine combining machine learning, synthetic biology, and robotic automation
Focus: Discovery and optimisation of therapeutic antibodies for oncology (selectivity-enhanced antibodies, multispecific formats, T-cell engagers)
Recent financing: Series B £35M closed May 21, 2024 (led by M Ventures); company-reported total funding ~£58M
Therapeutic antibody discovery and optimisation for oncology
2012
Biotechnology Research
£35,000,000
Company reported this round brought total funding to ~£58M
“Includes corporate VC and top-tier venture investors (M Ventures lead; participation from Octopus Ventures, LG, Atomico, Kindred Capital, Lux Capital, Obvious Ventures)”
| Company |
|---|
At LabGenius, our mission is to accelerate the discovery of next-generation therapeutic antibodies. To do this, we’ve pioneered the development of EVA™ - a smart robotic platform that’s capable of designing, conducting and, critically, learning from its own experiments.
For our wholly-owned pipeline, we’re using our closed-loop discovery engine to establish a pipeline of highly selective T-cell engagers and ADCs for the treatment of solid tumours.
LabGenius has raised >£58M and is backed by top-tier investors, including M Ventures, Octopus Ventures, LG Corp, Atomico, Kindred Capital, Lux Capital and Obvious Ventures amongst others.
The company is headquartered in London (UK) where we’ve established a state-of-the-art antibody engineering facility. The company is staffed by a multidisciplinary team of more than 50 scientists and engineers.
At LabGenius Therapeutics, we’re building a platform to discover revolutionary medicines using machine learning. We have exciting growth plans for the next 18 months and are looking for an experienced and passionate Phage Display Scientist to join us on our mission as we combine Machine Learning (ML), robotic automation and synthetic biology to evolve next-generation protein therapeutics.
As a Scientist at LabGenius Therapeutics, you will support our pipeline by conducting our lead discovery campaigns with minimal supervision. You will be experienced in phage display and antibody discovery, with a track record of delivering candidates for more in depth characterisation. You will be knowledgeable and with hands-on experience in different molecular biology methods. Our Antibody discovery team works at the interface with the functional assay and data science departments, hence you will enjoy working in a dynamic and creative environment, where a positive attitude and a great passion for science are highly valued. With an endless hunger for knowledge, learning, and growth, you will be contributing work that will positively impact humanity and fundamentally change scientific discovery forever!
What You’ll Do In This Role
What We’re Looking For
What You’ll Receive From Us Aside from being part of our brilliant, purpose-driven team, you’ll also enjoy:
Financial 💸
Health 🍏
Time-Off ⏰
Wellbeing 💛
Team-building 🤝
Diversity & Inclusion We believe that diversity makes for innovative, exceptional teams.
We are an equal opportunity employer and do not discriminate based on gender, race, colour, religion or belief, national origin, age, sexual orientation, marital status, disability, or any other protected class.
If you don't feel like you meet every single requirement of this role, we still want to hear from you! We encourage you to apply, have a discussion with us about the role or others that we may have at LabGenius either now or in the future, together we can build more inclusive workplaces.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
66,000+
Open Roles
1,300+
New This Week